1. Home
  2. GLMD
  3. GLMD News

Latest Galmed Pharmaceuticals Ltd. (GLMD) News on October 21, 2025

Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH
GLMD

PR Newswire

5 months ago

Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH

GLMD

Associated Press Finance

5 months ago

Galmed Pharmaceuticals: Q1 Earnings Snapshot

Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
GLMD

PR Newswire

5 months ago

Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models
GLMD

PR Newswire

5 months ago

Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models

Biotech Alert: Searches spiking for these stocks today
GLMD

TipRanks

5 months ago

Biotech Alert: Searches spiking for these stocks today

Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models
GLMD

PR Newswire

6 months ago

Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models

Biotech Alert: Searches spiking for these stocks today
GLMD

TipRanks

6 months ago

Biotech Alert: Searches spiking for these stocks today

GLMD

MT Newswires

6 months ago

Top Midday Gainers

GLMD

MT Newswires

6 months ago

Galmed Signs Term Sheet to Develop New Semaglutide Formulation; Shares Up

Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation
GLMD

PR Newswire

6 months ago

Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation

Galmed Pharmaceuticals Launches VCU Collaboration to Tackle Drug Resistance in GI Cancers
GLMD

PR Newswire

6 months ago

Galmed Pharmaceuticals Launches VCU Collaboration to Tackle Drug Resistance in GI Cancers

Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor
GLMD

PR Newswire

6 months ago

Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor

Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor
GLMD

PR Newswire

6 months ago

Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
GLMD

PR Newswire

7 months ago

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Galmed Pharmaceuticals Secures New Patent Grant Extending Aramchol's Patent Protection to 2039, Strengthening Leadership in NASH/MASH Combination Therapy
GLMD

PR Newswire

7 months ago

Galmed Pharmaceuticals Secures New Patent Grant Extending Aramchol's Patent Protection to 2039, Strengthening Leadership in NASH/MASH Combination Therapy

GLMD

Associated Press Finance

a year ago

Galmed Pharmaceuticals: Q3 Earnings Snapshot

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
GLMD

PR Newswire

a year ago

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
GLMD

PR Newswire

a year ago

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases

GLMD

MT Newswires

a year ago

Top Premarket Decliners

GLMD

MT Newswires

a year ago

Top Premarket Gainers

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
GLMD

PR Newswire

2 years ago

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023

Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
GLMD

PR Newswire

2 years ago

Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis

Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
GLMD

GlobeNewswire

2 years ago

Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center

GLMD

GlobeNewswire

2 years ago

ClimateRock and GreenRock Announce Filing of a Registration Statement in Connection with Proposed Business Combination

GLMD

Market Exclusive

2 years ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2023
GLMD

PR Newswire

2 years ago

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2023

SOBRsafe CEO Dave Gandini to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
GLMD

ACCESSWIRE

2 years ago

SOBRsafe CEO Dave Gandini to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024
GLMD

GlobeNewswire

2 years ago

BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024

Organigram Announces the First Tranche Closing from BAT Investment
GLMD

Business Wire

2 years ago

Organigram Announces the First Tranche Closing from BAT Investment

Texas Municipality Expands Use of Knightscope Emergency Communications
GLMD

Business Wire

2 years ago

Texas Municipality Expands Use of Knightscope Emergency Communications

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely
GLMD

Simply Wall St.

2 years ago

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Kaival Brands Innovations Group Announces Reverse Stock Split
GLMD

GlobeNewswire

2 years ago

Kaival Brands Innovations Group Announces Reverse Stock Split

Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems
GLMD

GlobeNewswire

2 years ago

Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems

INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
GLMD

ACCESSWIRE

2 years ago

INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Organigram Announces Appointment of Karina Gehring to Board of Directors
GLMD

Business Wire

2 years ago

Organigram Announces Appointment of Karina Gehring to Board of Directors

Edible Garden Receives OSHA Grant from the Michigan Occupational Safety and Health Administration
GLMD

GlobeNewswire

2 years ago

Edible Garden Receives OSHA Grant from the Michigan Occupational Safety and Health Administration

3 Stocks With the Best Shot to 10X by 2025
GLMD

InvestorPlace

2 years ago

3 Stocks With the Best Shot to 10X by 2025

Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
GLMD

GlobeNewswire

2 years ago

Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders

BranchOut Food Launches in the Bay Area Region of the Nation’s Largest Warehouse Club
GLMD

GlobeNewswire

2 years ago

BranchOut Food Launches in the Bay Area Region of the Nation’s Largest Warehouse Club

Immuron achieves record half yearly Travelan® sales
GLMD

GlobeNewswire

2 years ago

Immuron achieves record half yearly Travelan® sales

Horizon Aircraft Completes Business Combination with Pono Capital Three, Inc. to Become a Publicly Traded Company
GLMD

GlobeNewswire

2 years ago

Horizon Aircraft Completes Business Combination with Pono Capital Three, Inc. to Become a Publicly Traded Company

Trinity Place Holdings Inc. Enters Into Recapitalization Transactions
GLMD

Business Wire

2 years ago

Trinity Place Holdings Inc. Enters Into Recapitalization Transactions

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream
GLMD

GlobeNewswire

2 years ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

Third Avenue Management Reduces Stake in Trinity Place Holdings Inc
GLMD

GuruFocus.com

2 years ago

Third Avenue Management Reduces Stake in Trinity Place Holdings Inc

New to The Street TV Announces the Interviews of Four Corporate Guest, Episode 541, Airing on Bloomberg TV as Sponsored Programming, Tonight, Thursday, January 4, 2024, 9:30 PM PT
GLMD

GlobeNewswire

2 years ago

New to The Street TV Announces the Interviews of Four Corporate Guest, Episode 541, Airing on Bloomberg TV as Sponsored Programming, Tonight, Thursday, January 4, 2024, 9:30 PM PT

Laser Photonics to Exhibit DefenseTech Products at Upcoming Pearl Harbor Naval Shipyard NCMS Technology Showcase
GLMD

ACCESSWIRE

2 years ago

Laser Photonics to Exhibit DefenseTech Products at Upcoming Pearl Harbor Naval Shipyard NCMS Technology Showcase

Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings
GLMD

Simply Wall St.

2 years ago

Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings

Laser Photonics Receives Order From Ontario Power Generation for MarkStar Pro Laser Marking System
GLMD

ACCESSWIRE

2 years ago

Laser Photonics Receives Order From Ontario Power Generation for MarkStar Pro Laser Marking System

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
GLMD

GlobeNewswire

2 years ago

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
GLMD

Business Wire

2 years ago

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

ASHFORD SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES
GLMD

PR Newswire

2 years ago

ASHFORD SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES

GLMD

GlobeNewswire

2 years ago

Kanen Wealth Management Issues Letter To Real Good Food Company, Inc.’s Board of Directors

GLMD

Business Wire

2 years ago

The Beachbody Company, Inc. Announces Participation in the 2024 ICR Conference

Laser Photonics Receives Order From Fluor Corporation for MarkStar Pro Laser Marking System
GLMD

ACCESSWIRE

2 years ago

Laser Photonics Receives Order From Fluor Corporation for MarkStar Pro Laser Marking System

Movella Holdings Inc. Announces Leadership Transition
GLMD

GlobeNewswire

2 years ago

Movella Holdings Inc. Announces Leadership Transition

Super Trainer Shaun T Brings New 12-Week Weightlifting Program to BODi; Launches "DIG DEEPER," to Achieve Incredible Body Recomposition Transformation
GLMD

Business Wire

2 years ago

Super Trainer Shaun T Brings New 12-Week Weightlifting Program to BODi; Launches "DIG DEEPER," to Achieve Incredible Body Recomposition Transformation

Real Good Foods Announces Expansion of its Nutritious Burritos into the Refrigerated Category in Club Stores Nationwide & Select Walmart Stores
GLMD

GlobeNewswire

2 years ago

Real Good Foods Announces Expansion of its Nutritious Burritos into the Refrigerated Category in Club Stores Nationwide & Select Walmart Stores

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
GLMD

GlobeNewswire

2 years ago

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine
GLMD

GlobeNewswire

2 years ago

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
GLMD

GlobeNewswire

2 years ago

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome

GLMD

Business Wire

2 years ago

The Beachbody Company, Inc. Announces $5,300,000 Registered Direct Offering

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
GLMD

GlobeNewswire

2 years ago

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Exela Technologies Announces Adjournment of Annual Meeting
GLMD

GlobeNewswire

2 years ago

Exela Technologies Announces Adjournment of Annual Meeting

GLMD

GlobeNewswire

2 years ago

ClimateRock Announces Termination of Business Combination Agreement

Pension Benefit Guaranty Corporation Renews Comprehensive Risk Management Services Contract with CISO Global
GLMD

GlobeNewswire

2 years ago

Pension Benefit Guaranty Corporation Renews Comprehensive Risk Management Services Contract with CISO Global

Wheeler Will Likely Issue Unregistered Common Stock to Settle December Redemption Requests
GLMD

ACCESSWIRE

2 years ago

Wheeler Will Likely Issue Unregistered Common Stock to Settle December Redemption Requests

Investors Will Want Harte Hanks' (NASDAQ:HHS) Growth In ROCE To Persist
GLMD

Simply Wall St.

2 years ago

Investors Will Want Harte Hanks' (NASDAQ:HHS) Growth In ROCE To Persist

Take Care Before Jumping Onto The Real Good Food Company, Inc. (NASDAQ:RGF) Even Though It's 31% Cheaper
GLMD

Simply Wall St.

2 years ago

Take Care Before Jumping Onto The Real Good Food Company, Inc. (NASDAQ:RGF) Even Though It's 31% Cheaper

Billionaire Seth Klarman’s Biotech Stock Picks
GLMD

Insider Monkey

2 years ago

Billionaire Seth Klarman’s Biotech Stock Picks

BODi Helps End After-Dinner Suffering This Thanksgiving
GLMD

Business Wire

2 years ago

BODi Helps End After-Dinner Suffering This Thanksgiving

(Updated) MSSP Alert Names CISO Global to 2023 Top 250 Managed Security Services Providers List
GLMD

GlobeNewswire

2 years ago

(Updated) MSSP Alert Names CISO Global to 2023 Top 250 Managed Security Services Providers List

GLMD

InvestorPlace

2 years ago

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
GLMD

PR Newswire

2 years ago

Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study

ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s Disease
GLMD

GlobeNewswire

2 years ago

ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s Disease

Israel's Finance Ministry Increases Israel Innovation Authority's High-Tech Sector Fast-Track Fund to $100 Million During Wartime
GLMD

GlobeNewswire

2 years ago

Israel's Finance Ministry Increases Israel Innovation Authority's High-Tech Sector Fast-Track Fund to $100 Million During Wartime

Investors Holding Back On CaliberCos Inc. (NASDAQ:CWD)
GLMD

Simply Wall St.

2 years ago

Investors Holding Back On CaliberCos Inc. (NASDAQ:CWD)

3 Stocks You’ll Regret Not Buying Soon: November 2023
GLMD

InvestorPlace

2 years ago

3 Stocks You’ll Regret Not Buying Soon: November 2023

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript
GLMD

Insider Monkey

2 years ago

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript

One Hudson Global, Inc. (NASDAQ:HSON) Analyst Just Made A Major Cut To Next Year's Estimates
GLMD

Simply Wall St.

2 years ago

One Hudson Global, Inc. (NASDAQ:HSON) Analyst Just Made A Major Cut To Next Year's Estimates

ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights
GLMD

GlobeNewswire

2 years ago

ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights

Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
GLMD

GlobeNewswire

2 years ago

Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Sidoti Events, LLC’s Virtual November Micro-Cap Conference
GLMD

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

GLMD

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Theriva Biologics Inc Earnings Call

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
GLMD

GlobeNewswire

2 years ago

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Lendway, Inc. Announces Third Quarter 2023 Financial Results
GLMD

ACCESSWIRE

2 years ago

Lendway, Inc. Announces Third Quarter 2023 Financial Results

QNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory Approval
GLMD

Zacks Small Cap Research

2 years ago

QNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory Approval

GLMD

Associated Press Finance

2 years ago

Theriva Biologics: Q3 Earnings Snapshot

Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results
GLMD

GlobeNewswire

2 years ago

Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results

Harte Hanks, Inc. (NASDAQ:HHS) Q3 2023 Earnings Call Transcript
GLMD

Insider Monkey

2 years ago

Harte Hanks, Inc. (NASDAQ:HHS) Q3 2023 Earnings Call Transcript

Neonode Inc. (NASDAQ:NEON) Q3 2023 Earnings Call Transcript
GLMD

Insider Monkey

2 years ago

Neonode Inc. (NASDAQ:NEON) Q3 2023 Earnings Call Transcript

GLMD

Associated Press Finance

2 years ago

Harte-Hanks: Q3 Earnings Snapshot

electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript
GLMD

Insider Monkey

2 years ago

electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript

Rallybio to Present at Upcoming Investor Conferences in November
GLMD

Business Wire

2 years ago

Rallybio to Present at Upcoming Investor Conferences in November

Intellinetics to Host Third Quarter 2023 Financial Results Conference Call on November 14
GLMD

Business Wire

2 years ago

Intellinetics to Host Third Quarter 2023 Financial Results Conference Call on November 14

Israeli Ministry of Health Reports Surge in Medical Cannabis Patients Following Recent Events
GLMD

GlobeNewswire

2 years ago

Israeli Ministry of Health Reports Surge in Medical Cannabis Patients Following Recent Events

Theriva Biologics to Host Conference Call and Webcast to Discuss Third Quarter 2023 Operational Highlights and Financial Results
GLMD

GlobeNewswire

2 years ago

Theriva Biologics to Host Conference Call and Webcast to Discuss Third Quarter 2023 Operational Highlights and Financial Results

Share on Social Networks: